Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTIS2023-504430-22-00
CTIS2023-504430-22-00Active, not recruitingPhase 1

TA799-018

VectivBio AG0 sites33 target enrollmentStarted: April 3, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
33
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Ages
18 to 65+ (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06762340[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT04945941[Redacted]
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06733259[Redacted]
Completed
Not Applicable
Clinical Investigation (Beta) of a New Developed Prosthetic Knee
NCT06748729Össur Iceland ehf11
Withheld
Not Applicable
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT06422065[Redacted]